The relationship between insulin resistance/β-cell dysfunction and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study. 2018

Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China.

OBJECTIVE To investigate the relationship between insulin resistance (IR)/β-cell dysfunction and diabetic retinopathy (DR) in Chinese patients with type 2 diabetes mellitus (T2DM), and to explore further whether there were differences in the relationship among diabetic patients with higher and lower body mass index (BMI). METHODS Cross-sectional study. A total of 1466 subjects with T2DM were recruited in a local Desheng Community of urban Beijing from November 2009 to June 2012 for the cohort of Beijing Desheng Diabetic Eye Study. Standardized evaluation was carried out for each participant, including questionnaire, ocular and anthropometric examinations, and laboratory tests. Seven fields 30° color fundus photographs were used for DR grading according to the Early Treatment Diabetic Retinopathy Study protocols. Homeostatis Model Assessment (HOMA) method was employed for IR and β-cell function assessment. RESULTS After excluding those participants who were treated with insulin (n=352) or had missing data of fasting insulin (n=96), and further excluding those with poor quality of retinal photographs (n=10), a total of 1008 subjects were included for the final analysis, 406 (40.3%) were men and 602 (59.7%) were women, age ranging from 34 to 86 (64.87±8.28)y. Any DR (levels 14 and above) was present in 278 (27.6%) subjects. After adjusting for possible covariates, the presence of any DR did not correlate with HOMA IR [odds ratio (OR) 1.51, 95% confidence interval (CI) 0.87-2.61, P=0.14] or HOMA β-cell (OR 0.71, 95%CI 0.40-1.26, P=0.25). After stratification by BMI, the presence of any DR was associated positively with HOMA IR (OR 2.46, 95%CI: 1.18-5.12, P=0.016), and negatively with HOMA β-cell (OR 0.40, 95%CI: 0.19-0.87, P=0.021) in the group of patients with higher BMI (≥25 kg/m2). In the group of patients with lower BMI (<25 kg/m2), the presence of any DR was not associated with HOMA IR (OR 1.00, 95%CI: 0.43-2.33, P=1.00) or HOMA β-cell (OR 1.41, 95%CI: 0.60-3.32, P=0.43). CONCLUSIONS The data suggest that higher IR and lower β-cell function are associated with the presence of DR in the subgroup of diabetic patients with higher BMI. However, this association is not statistically significant in diabetic patients with lower BMI.

UI MeSH Term Description Entries

Related Publications

Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
October 2016, The British journal of ophthalmology,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
July 2017, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
January 2020, Diabetes, metabolic syndrome and obesity : targets and therapy,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
August 2013, Diabetes & metabolism journal,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
June 2017, Zhonghua yi xue za zhi,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
February 2015, The Journal of clinical endocrinology and metabolism,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
May 2024, Medicine,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
January 2012, International journal of endocrinology,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
January 2021, Diabetes, metabolic syndrome and obesity : targets and therapy,
Yun-Yun Li, and Xiu-Fen Yang, and Hong Gu, and Torkel Snellingen, and Xi-Pu Liu, and Ning-Pu Liu
April 2024, Endocrine,
Copied contents to your clipboard!